Share chart AxoGen
Extended chart
Simple chart
About
AxoGen — разработчик хирургических решений, в том числе трансплантатов тканей человека, базируется в Алачуа, Флорида. Продукция Axogen предназначена для лечения повреждений периферических нервов. В 2013 году компания привлекла 18 миллионов долларов в ходе первичного публичного размещения акций.Цена ао | 3.79 |
---|---|
P/S | 6.04 |
P/BV | 4.88 |
EV/EBITDA | -23.37 |
EBITDA | -0.0262 |
Сайт | http://www.axogeninc.com |
Число акций ао | 0.04288 млрд |
Выручка | 0.1067 |
Див.доход ао | 0 |
ISIN | US05463X1063 |
Дивиденд ао | 1 |
Валюта | usd |
IPO date | 1990-03-27 |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Валюта отчета | usd |
Change price per day: | +8.16% (13.6) |
---|---|
Change price per week: | +7.61% (13.67) |
Change price per month: | +8.4% (13.57) |
Change price per 3 month: | +69.86% (8.66) |
Change price per half year: | +110.14% (7) |
Change price per year: | +269.6% (3.98) |
Change price per 3 year: | +52.28% (9.66) |
Change price per 5 year: | +69.47% (8.68) |
Change price per 10 year: | +358.26% (3.21) |
Change price per year to date: | +288.13% (3.79) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
01.09.2024 | 04.09.2024 | Levine Alan M Director |
Purchase | 13.06 | 155 466 | 11904 | 0 | 0.03 | link |
01.09.2024 | 04.09.2024 | NEELS GUIDO J Director |
Purchase | 13.06 | 155 466 | 11904 | 0 | 0.03 | link |
01.09.2024 | 04.09.2024 | JOHNSON JOHN Director |
Purchase | 13.06 | 155 466 | 11904 | 0 | 0.03 | link |
21.03.2024 | 25.03.2024 | Donovan Michael Patrick VP Operations |
Sale | 7.68 | 46 333 | 6033 | 0 | -0.01 | link |
21.03.2024 | 25.03.2024 | Scopelianos Angelo Chief R&D Officer |
Sale | 7.68 | 52 846 | 6881 | 0 | -0.02 | link |
21.03.2024 | 25.03.2024 | Scopelianos Angelo Chief R&D Officer |
Purchase | 7.42 | 18 550 | 2500 | 0 | 0.01 | link |
21.03.2024 | 25.03.2024 | DeVinney Erick Wayne Chief Innovation Officer |
Sale | 7.68 | 35 159 | 4578 | 0 | -0.01 | link |
21.03.2024 | 25.03.2024 | Zaderej Karen L. CEO |
Sale | 7.68 | 301 670 | 39280 | 0 | -0.09 | link |
16.03.2024 | 25.03.2024 | Donovan Michael Patrick VP Operations |
Purchase | 7.42 | 182 347 | 24575 | 0 | 0.06 | link |
16.03.2024 | 25.03.2024 | Scopelianos Angelo Chief R&D Officer |
Purchase | 7.42 | 188 513 | 25406 | 0 | 0.06 | link |
16.03.2024 | 25.03.2024 | DeVinney Erick Wayne Chief Innovation Officer |
Purchase | 7.42 | 138 569 | 18675 | 0 | 0.04 | link |
16.03.2024 | 25.03.2024 | Zaderej Karen L. CEO |
Purchase | 7.42 | 818 589 | 110322 | 0 | 0.27 | link |
01.02.2023 | 01.02.2023 | MARIANI PETER J EVP & Chief Financial Officer |
Sale | 9.36 | 136 188 | 14550 | 0 | -0.04 | link |
25.07.2022 | 26.07.2022 | Freitag Gregory Gene Director |
Purchase | 3.38 | 280 540 | 83000 | 0 | 0.2 | link |
Institutions | Volume | Share, % |
---|---|---|
ArrowMark Colorado Holdings LLC | 5152300 | 11.79 |
Blackrock Inc. | 3342773 | 7.65 |
Morgan Stanley | 3082437 | 7.06 |
Soleus Capital Management, L.P. | 2595815 | 5.94 |
Vanguard Group Inc | 2465496 | 5.64 |
Millennium Management LLC | 1488720 | 3.41 |
DAFNA Capital Management, LLC | 935894 | 2.14 |
Geode Capital Management, LLC | 896336 | 2.05 |
Perceptive Advisors LLC | 808380 | 1.85 |
State Street Corporation | 792087 | 1.81 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Avantis U.S Small Cap Equity ETF | 0.05762 | 27.774101036841 | 1.68271 |
Avantis U.S. Equity ETF | 0.00037 | 30.365392144069 | 1.59151 |
Dimensional U.S. Core Equity 2 ETF | 0.00033 | 30.755198832543 | 1.47098 |
Dimensional US Core Equity Market ETF | 0.00139 | 30.983243755928 | 1.40618 |
Dimensional U.S. Equity ETF | 0.00082 | 31.530984204131 | 1.3557 |
WisdomTree U.S. SmallCap Fund | 0.03925 | 29.467482438251 | 1.80258 |
Fidelity Digital Health ETF | 1.3209 | 18.495626822157 | 0.44931 |
Franklin U.S. Small Cap Multifactor Index ETF | 0.07335 | 26.989243663262 | 1.90721 |
ProShares Hedge Replication ETF | 0.00376 | 5.9237999659878 | 1.47892 |
ROBO Global Healthcare Technology and Innovation ETF | 3.39918 | 19.559118236473 | 0.37496 |
iShares Neuroscience and Healthcare ETF | 1.08526 | 19.720292847757 | 0.03 |
iShares Micro-Cap ETF | 0.15138 | 34.327031588619 | 1.54048 |
iShares Russell 2000 Growth ETF | 0.04414 | 38.042556988 | 0.6026 |
iShares Russell 3000 ETF | 0.00105 | 31.230028873917 | 1.43482 |
Principal U.S. Small-Cap ETF | 0.02431 | 32.321772639692 | 1.20466 |
Schwab U.S. Small-Cap ETF | 0.01673 | -34.641922436355 | 1.51433 |
Schwab U.S. Broad Market ETF | 0.0012 | -56.193181818182 | 1.43354 |
ProShares UltraPro Russell2000 | 0.01289 | 89.821266282945 | 1.47873 |
Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
Vanguard Russell 2000 Growth ETF | 0.04 | 37.361289927043 | 0.60264 |
Vanguard Russell 2000 ETF | 0.02 | 32.773459189339 | 1.48801 |
SPDR S&P Health Care Equipment ETF | 0.4228 | 23.961682743837 | 0.35622 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Ms. Doris Quackenbush | Vice President of Sales | N/A | |
Mr. Marc A. Began | Executive VP, General Counsel & Chief Compliance Officer | N/A | 1968 (56 years) |
Mr. Jens Schroeder Kemp | Chief Marketing Officer | N/A | |
Mr. Erick DeVinney | Chief Innovation Officer | N/A | 1976 (48 years) |
Mr. Harold D. Tamayo | Vice President of Finance & Investor Relations | N/A | |
Dr. Ivica Ducic M.D., Ph.D. | Chief Medical Officer | N/A | |
Mr. Todd Puckett | Vice President of Operations | ||
Ms. Karen Zaderej | Advisor | 1962 (62 years) |
Address: United States, Alachua, FL , 13631 Progress Boulevard - open in Google maps, open in Yandex maps
Website: http://www.axogeninc.com
Website: http://www.axogeninc.com